ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer

BACKGROUND: Triple-negative breast cancers (TNBC) are poor-prognosis tumours candidate to chemotherapy as only systemic treatment. We previously found that PRICKLE1, a prometastatic protein involved in planar cell polarity, is upregulated in TNBC. We investigated the protein complex associated with...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Cancer
Autors principals: Daulat, Avais M., Finetti, Pascal, Revinski, Diego, Silveira Wagner, Mônica, Camoin, Luc, Audebert, Stéphane, Birnbaum, Daniel, Kodjabachian, Laurent, Borg, Jean-Paul, Bertucci, François
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6734648/
https://ncbi.nlm.nih.gov/pubmed/30971775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-019-0448-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars